Literature DB >> 6178013

Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.

M Margalith, H Falk, A Panet.   

Abstract

Three potential inhibitors of reverse transcriptase activities, phosphonoformate (PF), phosphonoacetate (PAA), and ethyl-diethyl phosphonoformate (Et-PF), were compared in this study. Only PF was found to inhibit the DNA polymerase activity of the purified reverse transcriptase of Moloney murine leukemia virus (M-MuLV) and avian myeloblastosis virus (AMV). The degree of DNA polymerase inhibition was linear with PF concentration; 50% inhibition was achieved at 10 muM. Whereas PF inhibited both the RNA and DNA dependent DNA polymerase activities, the RNase H activity of the reverse transcriptase was unaffected. Both the endogenous DNA polymerase activity in detergent disrupted virus and the activity of the purified enzyme with the isolated virus genome 70S RNA were inhibited by PF. However, higher concentrations of PF were needed to inhibit the endogenous reaction. The inhibition by PF appeared to be reversible and noncompetitive with respect to the substrate deoxythymidine triphosphate (dTTP). Addition of PF after the initiation of DNA synthesis immediately arrested the reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178013     DOI: 10.1007/BF00423097

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

1.  Enzymatic synthesis of deoxyribonucleic acid. IX. The polymerase formed after T2 bacteriophage infection of Escherichia coli: a new enzyme.

Authors:  H V APOSHIAN; A KORNBERG
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

2.  RNA metabolism of murine leukemia virus: detection of virus-specific RNA sequences in infected and uninfected cells and identification of virus-specific messenger RNA.

Authors:  H Fan; D Baltimore
Journal:  J Mol Biol       Date:  1973-10-15       Impact factor: 5.469

3.  Phosphonoformate inhibition of visna virus replication.

Authors:  B Sundquist; E Larner
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

4.  Inhibition of cytomegalovirus late antigens by phosphonoformate.

Authors:  B Wahren; B Oberg
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

5.  The effect of pyrophosphate analogues on influenza virus RNA polymerase and influenza virus multiplication.

Authors:  S Stridh; E Helgstrand; B Lannerö; A Misiorny; G Stening; B Oberg
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

6.  Inhibition of hepatitis B Dane particle DNA polymerase activity by pyrophosphate analogs.

Authors:  E Nordenfelt; B Oberg; E Helgstrand; E Miller
Journal:  Acta Pathol Microbiol Scand B       Date:  1980-06

7.  Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase.

Authors:  B Eriksson; A Larsson; E Helgstrand; N G Johansson; B Oberg
Journal:  Biochim Biophys Acta       Date:  1980-03-28

8.  Inhibition of activities of DNA polymerase alpha, beta, gamma, and reverse transcriptase of L1210 cells by phosphonoacetic acid.

Authors:  H S Allaudeen; J R Bertino
Journal:  Biochim Biophys Acta       Date:  1978-10-24

9.  Measurement of the sequence complexity of cloned Moloney murine leukemia virus 60 to 70S RNA: evidence for a haploid genome.

Authors:  H Fan; M Paskind
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

10.  Binding of tRNA to reverse transcriptase of RNA tumor viruses.

Authors:  A Panet; H Berliner
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

View more
  4 in total

1.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.

Authors:  K B Frank; P A McKernan; R A Smith; D F Smee
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

3.  Use of recombinant retroviruses to characterize the activity of antiretroviral compounds.

Authors:  R K Stair; C J Nelson; J W Mellors
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Authors:  R K Robins
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.